14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Aug 11, 2023 Buy 200 000 Breen Michael Martin Common Stock
Aug 11, 2023 Buy 200 000 Ohri Manu Common Stock
Aug 11, 2023 Buy 200 000 Ohri Manu Common Stock
Aug 11, 2023 Sell 200 000 Ohri Manu Common Stock
Jun 16, 2023 Buy 500 000 Casamento Charles J Option to purchase Common Stock
May 01, 2023 Buy 0 Casamento Charles J
Apr 11, 2023 Buy 50 000 Breen Michael Martin Common Stock
Apr 06, 2023 Buy 50 000 Ohri Manu Common Stock
Jan 27, 2023 Buy 500 000 Breen Michael Martin Option to purchase Common Stock
Jan 27, 2023 Buy 500 000 Ohri Manu Option to purchase Common Stock
Jan 27, 2023 Buy 500 000 Shrotriya Rajesh C Md Option to purchase Common Stock
Jan 27, 2023 Buy 500 000 Wendel Bruce Option to purchase Common Stock
Jul 15, 2022 Buy 50 000 Breen Michael Martin Option to purchase Common Stock
Jul 15, 2022 Buy 50 000 Shrotriya Rajesh C Md Option to purchase Common Stock
Jul 15, 2022 Buy 50 000 Urban Alan Louis Option to purchase Common Stock
Jul 15, 2022 Buy 50 000 Urban Alan Louis Option to purchase Common Stock
Jul 15, 2022 Buy 50 000 Berk Gregory Option to purchase Common Stock
Jul 15, 2022 Buy 50 000 Berk Gregory Option to purchase Common Stock
Jul 15, 2022 Buy 200 000 Ohri Manu Option to purchase Common Stock
Jul 15, 2022 Sell 100 000 Ohri Manu Common Stock
Jul 15, 2022 Buy 50 000 Wendel Bruce Option to purchase Common Stock
Jun 09, 2022 Buy 0 Urban Alan Louis
Feb 14, 2022 Buy 0 Ohri Manu
Dec 31, 2021 Buy 227 500 Choy Gavin Option to purchase Common Stock
Nov 28, 2021 Buy 0 Choy Gavin
Feb 25, 2021 Buy 9 859 Breen Michael Martin Common Stock
Feb 25, 2021 Buy 40 243 Breen Michael Martin Common Stock
Feb 25, 2021 Sell 30 000 Breen Michael Martin 10% Senior Convertible Debenture
Feb 16, 2021 Buy 278 058 Berk Gregory Common Stock
Feb 16, 2021 Buy 50 000 Berk Gregory Option to purchase Common Stock
Feb 16, 2021 Buy 50 000 Shrotriya Rajesh C Md Option to purchase Common Stock
Feb 16, 2021 Buy 278 058 Breen Michael Martin Common Stock
Feb 16, 2021 Buy 50 000 Breen Michael Martin Option to purchase Common Stock
Feb 16, 2021 Buy 347 572 Wendel Bruce Common Stock
Feb 16, 2021 Buy 50 000 Wendel Bruce Option to purchase Common Stock
Jan 13, 2021 Buy 0 Shrotriya Rajesh C Md
Dec 22, 2020 Buy 441 Wendel Bruce Common Stock
Dec 22, 2020 Buy 1 374 Wendel Bruce Common Stock
Dec 22, 2020 Sell 47 978 Weldon Steven W Common Stock
Dec 21, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 21, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 21, 2020 Sell 35 722 Weldon Steven W Common Stock
Dec 18, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 17, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 17, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 16, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 15, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 15, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 15, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 14, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 14, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 14, 2020 Sell 46 300 Weldon Steven W Common Stock
Dec 11, 2020 Sell 50 000 Weldon Steven W Common Stock
Dec 11, 2020 Sell 50 000 Weldon Steven W Common Stock
Nov 16, 2020 Buy 3 268 Wendel Bruce Common Stock
Nov 11, 2020 Buy 0 Berk Gregory
Nov 11, 2020 Buy 0 Wendel Bruce
Jun 23, 2020 Buy 0 Breen Michael Martin 10% Senior Convertible Debenture
Jun 02, 2020 Sell 4 234 320 Cataldo Tony common stock
May 13, 2020 Sell 2 269 708 Weldon Steven W common stock
Aug 14, 2019 Buy 7 000 000 Cataldo Tony common stock
Aug 14, 2019 Buy 4 500 000 Weldon Steven W common stock
Feb 06, 2019 Sell 800 000 Cataldo Tony common stock
Feb 01, 2019 Sell 176 980 Urbanski Raymond W. common stock
Nov 16, 2017 Buy 0 Cross Shawn
Nov 02, 2017 Sell 200 000 Cataldo Tony common stock
Nov 02, 2017 Sell 100 000 Cataldo Tony common stock
Nov 02, 2017 Sell 3 000 000 Cataldo Tony common stock
Sep 01, 2017 Buy 5 129 660 Cataldo Tony common stock
Sep 01, 2017 Buy 0 Urbanski Raymond W. common stock
Sep 01, 2017 Buy 0 Clarence-smith Kathleen common stock
Sep 01, 2017 Buy 2 566 835 Weldon Steven W common stock
Sep 01, 2017 Buy 0 Silverman Mark J Common Stock
Apr 05, 2016 Buy 250 000 Bristol Investment Fund Ltd Common Stock
Apr 04, 2016 Sell 675 000 Bristol Investment Fund Ltd Common Stock
Feb 09, 2016 Buy 0 Bristol Investment Fund Ltd Common stock
Jan 25, 2016 Buy 0 Cataldo Tony Common Stock
Jan 25, 2016 Buy 0 Weldon Steven W Common Stock
Jan 13, 2016 Buy 0 Bristol Investment Fund Ltd Common Stock
Jan 13, 2016 Buy 3 912 447 Bristol Investment Fund Ltd Convertible notes
Mar 01, 2012 Buy 26 334 193 Saloff David Common Stock Option
Aug 31, 2011 Buy 538 713 Saloff David Common Stock Option
Jun 30, 2011 Buy 777 778 Saloff David Common Stock Option
Jun 27, 2011 Buy 250 000 Eaton Kenneth Haynes Common Stock Option
May 20, 2011 Buy 0 Dube Anshuman 12% Convertible Debenture due 2012
Dec 27, 2010 Sell 360 100 Dube Anshuman Common Stock
Dec 27, 2010 Sell 360 100 Theorem Group, Llc Common Stock
Dec 23, 2010 Sell 700 000 Dube Anshuman 0% Convertible Debenture
Dec 23, 2010 Buy 700 000 Dube Anshuman Common Stock
Dec 23, 2010 Sell 339 900 Dube Anshuman Common Stock
Dec 23, 2010 Sell 700 000 Theorem Group, Llc 0% Convertible Debenture
Dec 23, 2010 Buy 700 000 Theorem Group, Llc Common Stock
Dec 23, 2010 Sell 339 900 Theorem Group, Llc Common Stock
Oct 01, 2010 Buy 250 000 Hoog Thomas W Non-qualified Stock Option (right to buy)
Aug 31, 2010 Sell 69 600 Post Gary M Common Stock
Aug 26, 2010 Sell 76 060 Post Gary M Common Stock
Oct 01, 2009 Buy 900 000 Dube Anshuman Series A Warrant
Oct 01, 2009 Buy 900 000 Dube Anshuman Series B Warrant
Oct 01, 2009 Sell 900 000 Theorem Group, Llc Series A Warrant
Oct 01, 2009 Sell 900 000 Theorem Group, Llc Series B Warrant
INSIDER POWER
53.110
Last 100 transactions
Buy: 58 045 999 | Sell: 17 311 668 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 53.110.

In total, the insiders bought 58 045 999 and sold 17 311 668 GTBP shares in the last 100 trades.

Click to get the best stock tips daily for free!

About GT Biopharma, Inc.

GT Biopharma. GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed ... GTBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT